MetroWest Medical Center is a teaching hospital in Framingham and Natick, Massachusetts. It is the largest health care provider in the MetroWest region between Boston and Worcester.

During the past decade, MetroWest Medical Center-Framingham Union Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 22 clinical trials were completed, i.e. on average, 183.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MetroWest Medical Center-Framingham Union Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Gilead Sciences" with 5 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MetroWest Medical Center-Framingham Union Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "MetroWest Medical Center-Framingham Union Hospital" are "Breast Cancer" (5 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "MetroWest Medical Center-Framingham Union Hospital" in a lesser frequency.

Most popular intervention types in "MetroWest Medical Center-Framingham Union Hospital" are "Drug" (28 trials), "Other" (17 trials), "Biological" (8 trials), "Radiation" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Placebo" (5 trials), "Paclitaxel" (4 trials), "Quality-of-Life Assessment" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "MetroWest Medical Center-Framingham Union Hospital" are 29 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "MetroWest Medical Center-Framingham Union Hospital". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in MetroWest Medical Center-Framingham Union Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MetroWest Medical Center-Framingham Union Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".